Trial to Evaluate the Impact of Various Behavioural Interventions to Increase Mammography Uptake Among Singaporean Women
PROMPT
Two Parallel Randomized Controlled Trials to Evaluate Outreach Strategies for Increasing Mammogram Uptake in Women Who Have Never Screened or Are Due for Repeat Screening
1 other identifier
interventional
8,910
1 country
1
Brief Summary
Breast cancer is the leading cancer among women in Singapore, yet mammography screening rates remain critically low at 34.7%, despite the availability of a national program since 2002. This shortfall significantly limits the potential of screening to reduce mortality at a population level. While various behavioral interventions have been tested internationally to increase uptake, their applicability in the local context remains uncertain. Existing studies in Singapore are either outdated, small in scale, or not sufficiently targeted. In particular, two subgroups of women warrant closer examination due to the scarcity of data: (1) never-screeners: those who have never undergone a mammogram and (3) recent screeners: those who had a mammogram more than two years ago but have not scheduled their next one. These cohorts exhibit distinct behavioral and psychological barriers that prevent adherence to regular, guideline-recommended screening. E.g., key barriers for never- screeners include low perceived susceptibility to breast cancer, lack of awareness about the benefits of early detection, fear or anxiety about pain or receiving a cancer diagnosis, cultural or personal modesty concerns or lack of a physician's recommendation. In contrast, the repeat recent screeners often have a misconception that a single normal result is sufficient, negative experiences during prior screenings (e.g., false positives, pain), absence of reminder systems and competing life priorities and lack of time. Among these, engaging never-screeners is particularly challenging, as they may not perceive screening as personally relevant or necessary, and many have successfully avoided the healthcare system for years. Yet, failure to engage these groups; poses a significant public health concern, as it undermines the effectiveness of population-level cancer control strategies. The PROMPT study is designed to fill this critical gap by systematically evaluating multiple low-cost, scalable outreach strategies in two parallel randomized trials. Its findings will provide robust, local evidence to inform policy and improve engagement of these hard-to-reach populations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 17, 2025
CompletedFirst Submitted
Initial submission to the registry
December 2, 2025
CompletedFirst Posted
Study publicly available on registry
December 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
December 29, 2025
December 1, 2025
1.1 years
December 2, 2025
December 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of Mammogram Uptake Between Interventional Arms (2-5) and Control Arm (Arm 1)
Comparison of the proportion of women who undergo surveillance mammography among participants in Arms 2-5 versus Arm 1 (control arm).
4 months from the time participants receive the reminders
Secondary Outcomes (3)
Impact of social and demographic factors on mammogram completion.
4 months from the time participants receive the reminder
Post-trial telephone survey
1-2 months post-trial
Mammogram uptake at 6 and 12 months post-trial
6 and 12 months from the time participants received the first mailed reminder
Study Arms (5)
Control Arm (Arm 1)
NO INTERVENTIONDoes not receive any reminder to go for mammogram.
Arm 2: : One mailed reminder
EXPERIMENTALReceives a single mail reminder
Arm 3: Two mailed reminders
EXPERIMENTALReceives two mail reminders, 1 month apart
Arm 4: Mailed Reminder with Prescheduled Appointment
EXPERIMENTALRecieves a mailed reminder with prescheduled appointment
Arm 5: Mailed reminder with enhanced messaging
EXPERIMENTALReceives mailed reminder with enhanced messaging
Interventions
Receives a mailed reminder with basic information about breast cancer and instructions on scheduling a mammogram
Receives a mailed reminder + follow-up mailed reminder, 1 month after the first reminder
Receives one mailed reminder with a pre-scheduled appointment, with instructions to change appointment
Receives one mailed reminder with enhanced messaging motivating recipient to undergo screening
Eligibility Criteria
You may qualify if:
- Singaporean citizen
- Age 50-69
- Registered as a patient at the National University Hospital
- Registered and active user of NUHS App
- Signed up with Healthier SG with a primary care provider within the NUHS Primary Care Network
- For "never-screener" cohort: Must have never undergone mammogram screening
- For "repeat-screener" cohort : Must have completed screening in the last 18-24 months but have not booked their next appointment yet
You may not qualify if:
- Diagnosis of breast cancer in EPIC
- Mammogram done in the past 24 months in EPIC
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National University Hospital Singapore
Singapore, Singapore
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Soo-Chin Lee, MBBS, MRCP
National University Hospital Singapore, Singapore
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 2, 2025
First Posted
December 15, 2025
Study Start
November 17, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2027
Last Updated
December 29, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share